Standout Papers

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis 2011 2026 2016 2021 674
  1. Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis (2011)
    Paul O’Connor, Jerry S. Wolinsky et al. New England Journal of Medicine
  2. Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial (2014)
    Christian Confavreux, Paul O’Connor et al. The Lancet Neurology

Immediate Impact

6 from Science/Nature 65 standout
Sub-graph 1 of 19

Citing Papers

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
STING orchestrates the neuronal inflammatory stress response in multiple sclerosis
2024 Standout
2 intermediate papers

Works of Philippe Truffinet being referenced

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial
2014
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
2011 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Philippe Truffinet 1973 399 618 940 632 68 2.6k
Vesna Brinar 2567 565 768 1170 589 90 3.3k
Jeffrey Cohen 2387 690 705 914 764 51 2.9k
Marcelo Kremenchutzky 2408 350 747 972 644 63 3.1k
Dusan Stefoski 1684 535 456 633 581 56 2.7k
Daniel Wynn 2642 765 641 1117 990 49 3.5k
Mark S. Freedman 2825 482 915 1324 620 44 3.4k
O. R. Hommes 2657 353 846 1289 541 68 3.6k
Gavin Giovannoni 2955 928 801 1049 1194 62 3.6k
Douglas Jeffery 2672 548 755 1194 755 82 3.6k
Joachim Burman 1570 666 272 644 786 109 2.7k

All Works

Loading papers...

Rankless by CCL
2026